Was PharmaEssentia Corporation hit by ransomware?

PharmaEssentia Corporation was listed by the thegentlemen ransomware operation (Taiwan), and stolen data was published on the group's leak site. Darkfield tracks this disclosure with the original leak post, screenshot and group context.

Who is the thegentlemen ransomware group?

thegentlemen is a ransomware operator tracked by Darkfield. See the full operator dossier for its known victims, sectors targeted, IOCs and leak-site infrastructure.

What data was leaked in the PharmaEssentia Corporation breach?

thegentlemen published data attributed to PharmaEssentia Corporation. Darkfield captured the leak post and a screenshot of the listing.

Ransomware victim disclosure

← All victims

PharmaEssentia Corporation

Claimed by Thegentlemen · listed 3 days ago

Age

since listed · data leaked

Status timeline

ListedSep 9, 2026
Data leakeddate unknown

At a glance

Group: Thegentlemen
Status: Data leaked
Country: Taiwan
Sector: Healthcare
Listed on leak site: Sep 9, 2026

About the victim

AI dossier — public-source company profile

PharmaEssentia is a Taiwanese biopharmaceutical company founded in 2003, specializing in therapies for myeloproliferative neoplasms (MPNs) and rare blood cancers. The company developed BESREMi® (ropeginterferon alfa-2b), the first drug developed in Taiwan approved by the FDA (2021), and operates globally across North America, Europe, Japan, Korea, and Asia-Pacific regions.

Industry: Biopharmaceutical — Rare Blood Disorder Therapies
Founded: 2003

Attack summary

Severity: low — No attack details, no proof files, no data exfiltration or encryption claimed. The 'leak post' is a public company profile with no malicious disclosure component visible.

The leak post does not describe an attack; it contains only a company profile and public financial/clinical information. No claim of encryption, exfiltration, or data compromise is stated in the disclosed material.

low

What the group claims

pharmaessentia.com zoominfo.com/c/pharmaessentia-corp/145441146 PharmaEssentia Taiwanese global biopharma founded in 2003, known for besremi® (ropeginterferon alfa-2b) — the first drug developed in Taiwan ever approved by the FDA (2021) and the only polycythemia vera (PV) therapy approved in both the US and EU. Its innovation: a mono-pegylated long-acting interferon dosed every 2 weeks at home, with disease-modifying potential (reducing JAK2V617F mutant allele frequency) — a premium rare-disease asset vs. hydroxyurea and Jakafi. Financials: $197M+ revenue in 2024 (~89% gross margin), TPEX-listed (6446) with a ~5x stock rally since 2024; next bets: essential thrombocythemia (ET) Phase 3 and myelofibrosis. Bottom line: the Taiwanese biotech that proved a local startup can take a molecule from out-license to FDA approval and global commercialization — a rare-disease champion with an expanding moat.

Sources

Victim sitepharmaessentia.com

Source

Indexed 3 days ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About thegentlemen

thegentlemen is a ransomware group that emerged in September 2025, operating with apparent financial motivations based on their broad targeting of commercial sectors. The group has documented 267 victims across multiple countries, with primary focus on the United States, Thailand, France, Brazil, and India. Their targeting strategy demonstrates a preference for high-value sectors including manufacturing, technology, healthcare, and financial services organizations. Given the group's recent emergence and limited public documentation from established threat intelligence sources such as CISA, FBI, or major security research firms, specific details regarding their country of origin, operational structure, attack methodologies, encryption techniques, and whether they employ ransomware-as-a-service models remain unclear. The relatively high victim count of 267 in a short operational timeframe since September 2025 suggests either an aggressive campaign pace or potential inflation of victim numbers through affiliate operations, though without corroborating intelligence reports, the group's exact operational capabilities and notable campaigns cannot be definitively established. Current intelligence indicates the group remains active as of late 2025, though comprehensive threat profiling requires additional validated reporting from authoritative cybersecurity sources. The group has been linked to 838 public disclosures across our corpus. First observed on a leak site on September 9, 2025; most recent post September 9, 2026. The operation is currently active.

Also tracked as: the gentlemen.

Timeline of this disclosure

September 9, 2026PharmaEssentia Corporation listed by thegentlemen on the group's public leak site

Other recent disclosures by thegentlemen

thegentlemen has been linked to 838 public victims on Darkfield. A sample of the most recent:

See the full thegentlemen dossier →

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,608 disclosures indexed across all operators we track. Geographically, PharmaEssentia Corporation is reported in Taiwan, a country with 58 ransomware disclosures in our corpus.

If your organisation is affected

A listing by thegentlemen means PharmaEssentia Corporation appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
Monitor for the data appearing on thegentlemen's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.